McElhaugh Michael J. has filed 8 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 177000 shares of Arbutus Biopharma Corp ($ABUS) on February 14, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | Arbutus Biopharma Corp | $ABUS | McElhaugh Michael J. | Interim President & CEO | A | Common Shares | 177000 | $0.00 | 1,658,003.0000 | 0 | 11.95% | 0.00% |
| Feb. 14, 2025 | Arbutus Biopharma Corp | $ABUS | McElhaugh Michael J. | Interim President & CEO | A | Stock Option (Right to Buy) | 718800 | $0.00 | 718,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2025 | Arbutus Biopharma Corp | $ABUS | McElhaugh Michael J. | Interim President & CEO | S | Common Shares | 23790 | $3.28 | 1,481,003.0000 | 0 | 1.58% | 0.00% |
| Feb. 1, 2024 | Arbutus Biopharma Corp | $ABUS | McElhaugh Michael J. | Interim President & CEO | A | Common Shares | 123800 | $0.00 | 1,514,957.0000 | 0 | 8.90% | 0.00% |
| Feb. 2, 2024 | Arbutus Biopharma Corp | $ABUS | McElhaugh Michael J. | Interim President & CEO | S | Common Shares | 10164 | $2.31 | 1,504,793.0000 | 0 | 0.67% | 0.00% |
| Feb. 1, 2024 | Arbutus Biopharma Corp | $ABUS | McElhaugh Michael J. | Interim President & CEO | A | Stock Option (Right to Buy) | 495100 | $0.00 | 495,100.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Arbutus Biopharma Corp | $ABUS | McElhaugh Michael J. | Chief Business Officer | A | Common Shares | 83700 | $0.00 | 1,391,157.0000 | 0 | 6.40% | 0.00% |
| Feb. 1, 2023 | Arbutus Biopharma Corp | $ABUS | McElhaugh Michael J. | Chief Business Officer | A | Stock Option (Right to Buy) | 334700 | $0.00 | 334,700.0000 | 0 | 9999.99% | 0.00% |